6 min read

Alternative Treatment of Arthritis / Arthrosis with Cannabis and CBD (RESEARCH 2019)

Cannabis can help in treating arthritis, studies show. Moreover, it helps in treating dependencies on previously used medications and overdose is not a risk. According to published studies, medical cannabis is a safer and more long-term treatment method. Cannabis can help with chronic pain in joints, muscles, ligaments, and spine.

Medicinal cannabis and arthritis: a scientific perspective

Arthritis represents a significant medical challenge that affects millions of people worldwide. Although traditionally associated with people over 60 years of age, this condition can appear at any stage of life, even in childhood in exceptional cases.

Conventional treatments include various medications and topical preparations; however, not all patients experience satisfactory relief. In this context, research on medicinal cannabis has gained relevance as a complementary therapeutic alternative.

Anti-inflammatory properties of cannabinoids

Recent scientific studies have identified particular characteristics in the cannabinoid profile of cannabis that are especially interesting for medical research. CBD (cannabidiol) stands out for its non-psychoactive profile and its documented anti-inflammatory properties.

  • Interaction with the endocannabinoid system
  • Modulation of inflammatory responses
  • Potential to reduce joint discomfort
  • Favorable safety profile compared to some traditional treatments

Cannabis strains with high CBD content

The genetics Charlotte's Web, developed specifically for its high CBD levels, has been the subject of numerous studies. This strain presents a unique cannabinoid profile with especially high CBD:THC ratios, which makes it a genetics of interest for medical research.

Other strains such as Harlequin and ACDC also show similar characteristics, with terpene profiles rich in myrcene with earthy tones and limonene, which contribute to the entourage effect documented in the scientific literature.

Current clinical research

Preclinical studies have shown that certain cannabinoids can interact with specific receptors of the endocannabinoid system, particularly CB1 and CB2, which are present in joint tissues and the immune system.

Results from observational studies

Observational research has documented patient experiences reporting improvements in their quality of life. A study published in 2019 analyzed more than 2,000 participants with various forms of arthritis, including:

  • Rheumatoid arthritis
  • Osteoarthritis
  • Psoriatic arthritis
  • Fibromyalgia

The results showed that 89% of participants reported some level of improvement in their symptoms after six months of follow-up.

Proposed mechanisms of action

Researchers have identified several potential mechanisms by which medicinal cannabis could benefit patients with arthritis. Research suggests that cannabinoids may:

Modulate the immune response: In vitro studies have shown that CBD can influence the production of pro-inflammatory cytokines, key molecules in the development of joint inflammatory processes.

Interact with pain receptors: Preclinical research indicates that cannabinoids can activate vanilloid receptors (TRPV1), involved in the perception of chronic pain.

Considerations on dosing and administration

Research protocols have explored various forms of medicinal cannabis administration, from sublingual oils to topical preparations. Dosage varies significantly between studies, generally ranging between 2.5-20mg of CBD per dose.

Studied administration methods

  • Sublingual oils: Allow direct absorption and precise dosing
  • Capsules: Offer consistent dosing and prolonged release
  • Topical preparations: Local application for specific joints
  • Vaporizers: Rapid onset of effects for acute episodes

The genetics Cannatonic, with its balanced 1:1 CBD:THC ratio, has been used in several research protocols for its balanced cannabinoid profile.

Safety profile and considerations

Long-term safety studies have shown a favorable profile for medicinal cannabis compared to some traditional pharmacological treatments. Reported adverse effects are generally mild and include transient drowsiness, changes in appetite, and occasionally mild gastrointestinal discomfort.

Research has also shown that, unlike some opioid analgesics, medicinal cannabis presents no risk of fatal overdose and shows a significantly lower potential for dependence.

Future research perspectives

The scientific community continues to explore the therapeutic potential of medicinal cannabis for inflammatory conditions. Randomized controlled clinical trials are currently in development to provide more robust evidence on efficacy and optimal treatment protocols.

Strains with specific terpene profiles, such as those rich in caryophyllene with spicy notes, are being investigated for their ability to interact with CB2 receptors, particularly abundant in immune system tissues.

This line of research represents a promising avenue for the development of more personalized and effective therapies for patients with arthritis and other chronic inflammatory conditions.